It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Gaining insight into the genetic regulation of gene expression in human brain is key to the interpretation of genome-wide association studies for major neurological and neuropsychiatric diseases. Expression quantitative trait loci (eQTL) analyses have largely been used to achieve this, providing valuable insights into the genetic regulation of steady-state RNA in human brain, but not distinguishing between molecular processes regulating transcription and stability. RNA quantification within cellular fractions can disentangle these processes in cell types and tissues which are challenging to model in vitro. We investigated the underlying molecular processes driving the genetic regulation of gene expression specific to a cellular fraction using allele-specific expression (ASE). Applying ASE analysis to genomic and transcriptomic data from paired nuclear and cytoplasmic fractions of anterior prefrontal cortex, cerebellar cortex and putamen tissues from 4 post-mortem neuropathologically-confirmed control human brains, we demonstrate that a significant proportion of genetic regulation of gene expression occurs post-transcriptionally in the cytoplasm, with genes undergoing this form of regulation more likely to be synaptic. These findings have implications for understanding the structure of gene expression regulation in human brain, and importantly the interpretation of rapidly growing single-nucleus brain RNA-sequencing and eQTL datasets, where cytoplasm-specific regulatory events could be missed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University College London, Department of Neurodegenerative Disease, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201); King’s College London, Guy’s Hospital, Department of Medical & Molecular Genetics, School of Medical Sciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); University College London, Department of Clinical and Movement Neurosciences, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
2 University College London, Department of Neurodegenerative Disease, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201); Verge Genomics, South San Francisco, USA (GRID:grid.83440.3b)
3 UCL Queen Square Institute of Neurology, Dept of Neuromuscular Disease, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
4 University College London, Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
5 University College London, Department of Neurodegenerative Disease, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201); UK Dementia Research Institute at University College London, London, UK (GRID:grid.511435.7) (ISNI:0000 0005 0281 4208)
6 University College London, Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201); Universidad de Murcia, Departamento de Ingeniería de la Información y las Comunicaciones, Murcia, Spain (GRID:grid.10586.3a) (ISNI:0000 0001 2287 8496)
7 King’s College London, Guy’s Hospital, Department of Medical & Molecular Genetics, School of Medical Sciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); Genomics Plc, Oxford, UK (GRID:grid.510940.9)
8 Université de Montréal, Department of Medicine, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136); Montréal Heart Institute, Montréal, Canada (GRID:grid.482476.b) (ISNI:0000 0000 8995 9090); Université de Montréal, Department of Neurosciences, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136)
9 King’s College London, Department of Twin Research and Genetic Epidemiology, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
10 University College London, Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201); NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)




